# Temporomandibular Joint Arthrocentesis With Infiltration of PRP + Ropivacaine Versus PRP

> **NCT05817162** · PHASE4 · UNKNOWN · sponsor: **Instituto Portugues da Face** · enrollment: 30 (estimated)

## Conditions studied

- Temporomandibular Joint Disorders

## Interventions

- **DRUG:** Ropivacaine injection
- **PROCEDURE:** temporomandibular joint arthrocentesis
- **DRUG:** PRP injection
- **DRUG:** Ringer's Lactate solution

## Key facts

- **NCT ID:** NCT05817162
- **Lead sponsor:** Instituto Portugues da Face
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05817162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05817162, "Temporomandibular Joint Arthrocentesis With Infiltration of PRP + Ropivacaine Versus PRP". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05817162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*